Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Does the use of the Bruton Tyrosine Kinase inhibitors and the c-kit inhibitor masitinib result in clinically significant outcomes among patients with various forms of multiple sclerosis?
Mult Scler Relat Disord. 2022 Nov;67:104164. doi: 10.1016/j.msard.2022.104164. Epub 2022 Sep 6.
Mult Scler Relat Disord. 2022.
PMID: 36126539
Review.
Models and Methods to Investigate Acute Stress Responses in Cattle.
Chen Y, Arsenault R, Napper S, Griebel P.
Chen Y, et al.
Animals (Basel). 2015 Dec 3;5(4):1268-95. doi: 10.3390/ani5040411.
Animals (Basel). 2015.
PMID: 26633525
Free PMC article.
Item in Clipboard
Interleukin-1 receptor antagonist: An exploratory plasma biomarker that correlates with disability and provides pathophysiological insights in relapsing-remitting multiple sclerosis.
Blandford SN, Galloway DA, Williams JB, Arsenault S, Brown J, MacLean G, Moore GRW, Barron J, Ploughman M, Clift F, Stefanelli M, Moore CS.
Blandford SN, et al.
Mult Scler Relat Disord. 2021 Jul;52:103006. doi: 10.1016/j.msard.2021.103006. Epub 2021 May 7.
Mult Scler Relat Disord. 2021.
PMID: 34004435
Item in Clipboard
Cite
Cite